EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma
Authors:
Open Access
- 29 July 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 126 (4) , 940-949
Abstract
Novel biomarkers are needed for early detection and progression evaluation of hepatocellular carcinoma (HCC). The purpose of this study was to identify useful biomolecular markers for HCC. The 26 genes that encode membrane or secretory proteins were identified from cDNA microarray data. We further examined the expression of EFNA1 and its receptor EphA2 and determined their biological implications during the development and progression of HCC. The EFNA1 mRNA was overexpressed in most HCCs as compared with its expression in corresponding nontumor tissues (36 out of 40 cases, 90%), but EphA2 expression was noted in only half of the HCC tissues (20 of 40 cases, 50%). In most of the hepatoma cell lines, the EFNA1 protein expression was positively associated with alpha‐fetoprotien (AFP) expression but inversely associated with EphA2 expression. Furthermore, EFNA1 levels were detectable in the supernatant of the cultured hepatoma cells and in the serum of patients with HCC. In contrast, EphA2 expression was prominent in highly invasive hepatoma cells, and its overexpression was significantly correlated with decreased differentiation (r = 0.0248, p < 0.010) and poor survival (p = 0.0453) for HCC patients. EFNA1 and EphA2 may be useful serum markers for the detection of HCC development and progression, respectively.Keywords
This publication has 33 references indexed in Scilit:
- The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic TargetingMolecular Cancer Research, 2008
- Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptorOncogene, 2008
- Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinomaExperimental & Molecular Medicine, 2007
- Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic statusClinical & Experimental Metastasis, 2006
- Expression Profiling of UVB Response in Melanocytes Identifies a Set of p53-Target GenesJournal of Investigative Dermatology, 2006
- Loss of Raf Kinase Inhibitor Protein Promotes Cell Proliferation and Migration of Human Hepatoma CellsGastroenterology, 2006
- Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinomaGut, 2005
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascadeOncogene, 2002
- Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosisOncogene, 2001